Navigation Links
Aussie neuroscientist tests addiction drug
Date:2/19/2008

UQ pharmacy graduate Dr Selena Bartlett is starting clinical trials of a new drug that could potentially curb addictions such as smoking, drinking, gambling even depression.

The drug, marketed as Chantix by Pfizer, has reduced alcohol consumption in laboratory rats by 50 percent and will be trialled in humans next month by Dr Bartlett and Dr Markus Heilig's team in the United States.

Chantix latches onto good feeling' receptors in the brain to block cravings for addictions such as nicotine or alcohol.

Dr Bartlett is the Director of the Preclinical Development Group at the Ernest Gallo Clinic and Research Centre, one of the world's top alcohol and addiction research centres, at the University of California in San Francisco.

She said she was convinced of the drug's potential but it had been hard to convince others, despite the drug gaining widespread media attention in the US.

Big companies still do not believe in the potential of addiction as a market, believe it or not, Dr Bartlett said.

The Chantix trials are just one of 10 major projects for Dr Bartlett's lab team, which is working on reducing ethanol consumption and new drug screening technologies.

Dr Bartlett was asked to set up her preclinical lab to study addiction and how it modifies brain function.

I wanted to make a difference in the world and develop treatments that would help people, she said.

Addiction is currently one of the most under-served and least understood.

Her passion for understanding brain functions stemmed from her late-sister who had schizophrenia.

She is still very much a driving force in my life and the reason I am doing this type of translational research.

She also hopes to create a Foundation to fund research and develop better treatments for neuropsychiatric diseases such as schizophrenia, in memory of her sister.

Dr Bartlett grew up in the small South B
'/>"/>

Contact: Miguel Holland
m.holland@uq.edu.au
61-733-652-619
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Brandeis neuroscientist wins NIH directors Pioneer Award
2. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
3. Leading neuroscientist seeks beauty, love and happiness
4. Carnegie Mellon neuroscientist proposes new theory of brain flexibility
5. Jefferson neuroscientists find early lead exposure impedes recovery from brain injury
6. MITs McGovern Institute honors Emory neuroscientist for contributions to psychiatry
7. Experts propose cholesterol tests at 15 months of age
8. Fecal Blood Tests Effective at Spotting Colon Cancer
9. Drug Industry Seeks Tests to Spot Side Effect Risks
10. Noninvasive tests for cirrhosis may help to avoid liver biopsy
11. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... 19, 2014 Silver Dollar City ... record -- for the first time ever, Silver Dollar City ... Guinness World Records 2015, listing the park’s wood coaster Outlaw ... In additional awards announced this week, Silver Dollar City is ... in the US,” USA Today’s 10Best awards for “Best Public ...
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... An evening dress is perfect for any occasion and ... distinguished dresses retailer, has unveiled its new selection of evening ... great shopping platform. Customers can view more at ... has been accepted and praised by customers for many years. ... for clients. In order to expand its market share, the ...
(Date:12/19/2014)... The print component of Vision and Hearing is ... Toronto Star, with a circulation of approximately 230,433 copies ... is distributed nationally through a vast social media strategy ... partner outlets. To explore the digital version of the ... an exclusive interview with Mark DeMontis , sharing ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... investigators Lewis C. Cantley, PhD, and Cornelius P. Terhorst, PhD, ... American Association for the Advancement of Science. They are ... distinguished efforts to advance science, and will be honored during ... BIDMC,s Division of Signal Transduction and Director of the BIDMC ...
... This release is available in German . ... of recovery depending on disease stage. Experts hope that the ... is more helpful in the choice of the right treatment ... for Quality and Efficiency in Health Care (IQWiG) has now ...
... 2011 HIV-positive head and neck cancer patients respond ... rates as non-HIV-positive patients, despite prior reports to the ... of the International Journal of Radiation OncologyBiologyPhysics , ... Oncology (ASTRO). , Patients with HIV have a significantly ...
... The combined results of a genetic blood test and ... of healthy older adults, many of whom were destined ... John Woodard, Ph.D., associate ... and Sciences and Institute of Gerontology at Wayne State ...
... (Jan. 19, 2011) A new program designed to create ... Colorado has received a $3.9 million grant from the Colorado ... four-year program housed in the Department of Family Medicine at ... brings together local and national leaders from the mental health, ...
... Dotinga HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay ... that aims to reveal the presence of Alzheimer,s disease, potentially ... early stages. Another study finds that blood tests could indicate ... there,s a catch: Alzheimer,s disease is not curable, and existing ...
Cached Medicine News:Health News:Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable 2Health News:HIV-positive head and neck cancer patients benefit from radiation therapy 2Health News:Wayne State University study predicts risk of memory loss in healthy, older adults 2Health News:New program targeting whole-person health care gets major grant 2Health News:Progress Reported in Predicting Alzheimer's 2
(Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
(Date:12/19/2014)... , Dec. 18, 2014 Baptist Health Lexington is ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) ... Atrial fibrillation is the most common cardiac arrhythmia ... some cases can lead to stroke and possible death. More ... have atrial fibrillation and the numbers are rapidly ...
(Date:12/19/2014)... membrane market has witnessed robust development with the growth pace ... later starter. In 2012, the size of China ... the proportion worldwide soaring to 16.3%. It is projected that ... its growth rate by around 20% in the upcoming years ... RMB25 billion. An integrated membrane industrial system has ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... 2011 Nephros, Inc. (OTC Bulletin Board: NEPHD ... for therapeutic applications, infection control, and water purification, announced today ... December 31, 2010. 2010 Highlights ... prior year period Increased gross margin by 22% to ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a proposal to the Board of Directors of Cephalon, ... for $73.00 per share in cash.  The proposal, valued ... 29% over Cephalon,s 30-day trading average.  Valeant announced its ...
Cached Medicine Technology:Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 2Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 3Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 4Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 5Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 6Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 7Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 8Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 9Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 2Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 3Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 4Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 5Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 6Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 7Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 8Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 9Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 10Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 11Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 12